how much does glp 1 cost through hers Hims & swings to a loss in Q1 amid shift in GLP-1 strategy Hims & Hers announces access

Phase 3 REDEFINE trials confirmed 50% greater weight loss compared to semaglutide alone, with 43% of participants achieving over 20% body weight loss

By Patricia Van Arnum, Editorial Director, DCAT, [email protected] Whats next Glucagon-like peptide 1 (GLP-1) agonists, used to treat Type 2 diabetes and obesity, have been a success story in the industry, with Novo Nordisk riding a blockbuster wave with Ozempic/Wegovy (semaglutide), respectively for treating Type 2 diabetes and obesity, and Eli Lilly and Company also riding the wave with Mounjaro/Zepbound (tirzepatide), a dual-activating GIP (glucose-dependent insulinotropic polypeptide) and GLP-1 medication, respectively for treating Type 2 diabetes and obesity

Hirsch, W

Build a protein-packed, low carb snack drawer for 2026 with bars, jerky, cheese crisps, nuts, and more

Danuglipron (Pfizer) is another oral GLP-1 currently in phase 2 trials, and CT-996 (Carmot Therapeutics) is in phase 1 trials

Plateaus, muscle loss, or shifts in appetite are normal, and staying flexible with your goals is key to long-term success